Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells

• Atsuo Kurata ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft

  * E-mail: kurata.atsuo@chugai-pharm.co.jp

  Affiliation Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan

  http://orcid.org/0000-0001-5906-7865

  ⨯
• Yukako Tachibana,

  Roles Formal analysis

  Affiliation Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan

  ⨯
• Tadakatsu Takahashi,

  Roles Investigation

  Affiliation Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan

  ⨯
• Naoshi Horiba

  Roles Writing – review & editing

  Affiliation Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan

  ⨯